Organon Pharma Indonesia Tbk. vs Integra Indocabinet Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Integra Indocabinet Tbk. trades at Rp204 (market cap 1.31T, 5.78M 24h volume). The key difference: Integra Indocabinet Tbk. is far larger — about 12.5× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | WOOD | |
|---|---|---|
Market Cap | 104.4B | 1.31T |
Volume | — | 5.78M |
Lot | — | 57.84K |
Turnover | — | 1.16B |
Average Price | — | 200.26 |
Value | — | 1.16B |
Indicative Equilibrium Price | — | 204 |
Indicative Equilibrium Volume | — | 56 |
Trailing returns across standard periods
Latest headlines on both assets
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →PT Integra Indocabinet Tbk (the Company or ITG) was established based on notarial deed No. 147 of Soetjipto, S.H., dated May 19, 1989.
Read more on WOOD →